vernal conjunctivitis
ORPHA: 704762 Treatments Available
Overview
Human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| tacrolimus ophthalmic | ophthalmic suspension 0.03%, 0.1% | Off-label use | 5 | 10d |
| cyclosporine ophthalmic Orphan | ophthalmic emulsion 0.05%, 0.09% | FDA Approved | 7 | 5d |
Clinical Presentation
Signs and symptoms associated with vernal conjunctivitis, sourced from HPO and Orphanet clinical annotations.
Abnormal cornea morphologyAbnormal conjunctiva morphologyAbnormal sclera morphologyPhotophobiaKeratoconjunctivitisAllergic conjunctivitisEpiphoraCorneal neovascularizationPunctate keratitisAllergyRed eyeConjunctival hyperemiaBlurred visionBlepharospasmGiant conjunctival papillaeOcular pruritusCorneal foreign body sensationScarringBlepharitisKeratoconusReduced visual acuityCorneal ulcerationLimbal stem cell deficiency
Classification & Codes
Orphanet Code
ORPHA:70476vernal conjunctivitis
| Orphanet | ORPHA:70476 |
| Treatments | 2 drug(s) |
| Symptoms on record | 23 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO